Clorox (CLX) Price Target Raised to $146.00 at Wells Fargo & Co

Clorox (NYSE:CLX) had its target price boosted by Wells Fargo & Co from $130.00 to $146.00 in a research note released on Thursday morning. The firm currently has a market perform rating on the stock.

Several other research firms also recently weighed in on CLX. Zacks Investment Research downgraded shares of Clorox from a hold rating to a sell rating in a research report on Wednesday, October 4th. Jefferies Group restated a hold rating and set a $132.00 price target (down previously from $137.00) on shares of Clorox in a research report on Friday, October 6th. Morgan Stanley reduced their price target on shares of Clorox from $138.00 to $128.00 and set an equal weight rating for the company in a research report on Thursday, November 2nd. Consumer Edge upgraded shares of Clorox from a neutral rating to an outperform rating in a research report on Friday, November 10th. Finally, BMO Capital Markets restated a buy rating and set a $150.00 price target on shares of Clorox in a research report on Thursday, October 5th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the stock. The company currently has an average rating of Hold and an average price target of $133.33.

Clorox (NYSE CLX) traded down $0.31 on Thursday, hitting $145.38. 218,569 shares of the company traded hands, compared to its average volume of 889,433. Clorox has a 52-week low of $118.41 and a 52-week high of $150.40. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10. The firm has a market cap of $18,493.66, a P/E ratio of 26.77, a PEG ratio of 3.87 and a beta of 0.42.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.05. Clorox had a net margin of 11.84% and a return on equity of 161.59%. The firm had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same quarter in the prior year, the firm earned $1.36 EPS. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. sell-side analysts expect that Clorox will post 5.65 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be paid a dividend of $0.84 per share. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a yield of 2.31%. Clorox’s dividend payout ratio is presently 61.88%.

In related news, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares of the company’s stock, valued at approximately $4,742,260.67. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the sale, the senior vice president now directly owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. 1.00% of the stock is currently owned by corporate insiders.

Several institutional investors have recently bought and sold shares of CLX. Victory Capital Management Inc. grew its stake in shares of Clorox by 19.8% in the 2nd quarter. Victory Capital Management Inc. now owns 19,414 shares of the company’s stock valued at $2,587,000 after buying an additional 3,206 shares during the period. Pacer Advisors Inc. grew its stake in shares of Clorox by 8.3% in the 2nd quarter. Pacer Advisors Inc. now owns 2,642 shares of the company’s stock valued at $352,000 after buying an additional 203 shares during the period. Cipher Capital LP purchased a new stake in shares of Clorox in the 2nd quarter valued at approximately $974,000. State of Tennessee Treasury Department grew its stake in shares of Clorox by 3.3% in the 2nd quarter. State of Tennessee Treasury Department now owns 79,920 shares of the company’s stock valued at $10,649,000 after buying an additional 2,554 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in shares of Clorox by 0.6% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,569 shares of the company’s stock valued at $1,275,000 after buying an additional 54 shares during the period. 73.14% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Clorox (CLX) Price Target Raised to $146.00 at Wells Fargo & Co” was originally posted by Transcript Daily and is owned by of Transcript Daily. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://transcriptdaily.com/2018/01/05/clorox-clx-price-target-raised-to-146-00-at-wells-fargo-co.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply